Practical PET/CT: What You Need to Know

PET/CT is an essential imaging study, largely serving the fields of oncology and neurology, that combines the sensitivity of providing physiologic data about pathologic conditions with the diagnostic capability of CT. This course focuses on many important practical issues in PET/CT, optimizing PET/CT protocols and image production, as well as interpretation and optimizing communication.  Particular attention is placed on the most recent updates and role of PET/CT in cancers diagnosis and treatment. Updates in dementia imaging with amyloid agents and F18-FDG are also discussed.

Learn and earn credit at your own pace with unlimited access to this course through November 6, 2020. See below for detailed information and learning outcomes.

PETCT Online Course

This course offers 10.5 CME/SA-CME Credits following completion of an online test.

ARRS Member price: $395
ARRS In-Training Member price: $199
Nonmember price: $899

Order Now

Learning Outcomes and Modules

At the conclusion of this activity, participants will be able to describe current and new utilization for digital breast tomosynthesis and its importance in clinical practice; evaluate screening recommendations and controversies along with benefits of screening mammography; utilize Breast MRI for the high risk patient and venues for the diagnostic patient or the average risk patient; explain breast density and its importance in breast cancer risk and risk assessment; and identify the latest applications of imaging technologies.

Module 1

  • History of PET and Clinical Overview—Marc Seltzer, MD
  • Importance of Patient Preparation—Don Yoo, MD
  • Optimizing PET/CT Protocols—Terence Wong, MD, PhD
  • Improving Your PET/CT Practice: Lessons Learned in Clinical Practice—Harry Agress, MD 

Module 2

  • Important Normal Variants and Pitfalls I—Esma Akin, MD
  • Important Normal Variants and Pitfalls II—Katherine Zukotynski, MD
  • PET/CT for Infection and Inflammation—Don Yoo, MD 

Module 3

  • Update on PET/CT in Lung Cancer—Rathan Subramaniam, MD, PhD 
  • Update on PET/CT in Lymphoma—Katherine Zukotynski, MD
  • Update on PET/CT in Head and Neck Cancer—Marc Seltzer, MD  

Module 4

  • Update on PET/CT in GU Malignancies—Mark Nathan, MD 
  • Update on PET/CT in Prostate Cancer—Mark Nathan, MD 
  • Interpreting F18-FDG and Strategies for Challenging Cases—Phillip Kuo, MD, PhD 
  • Moving to the Next Level: What Defines a True PET/CT Expert—Harry Agress, MD 

Module 5

  • Update on PET/CT in Melanoma—Eric Rohren, MD
  • Update on PET/CT in GYN Malignancies—Esma Akin, MD
  • PET/CT for Evaluation of Treatment Response—Rathan Subramaniam, MD, PhD
  • Update on the Role of Amyloid Imaging and Interpretation—Phillip Kuo, MD, PhD 

​Module 6

  • How to Generate a Great PET/CT Report—Eric Rohren, MD 
  • Important New Developments in PET—Terence Wong, MD, PhD 
  • The Most Instructive and Challenging PET/CT Cases—Don Yoo, MD

The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

The ARRS designates this enduring material for a maximum of 10.5 AMA PRA Category 1 Credit(s) and 10.5 American Board of Radiology, MOC Part II, Self-Assessment CME (SA-CME) credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.